|
2024
|
Invention
|
Treatment of alcohol-associated hepatitis. Methods of treating alcohol-associated hepatitis (AH) ... |
|
2023
|
Invention
|
25-hydroxy-cholest-5-en-3-sulfate choline, formulations thereof and methods for preparing, and me... |
|
|
Invention
|
Sustained release drug delivery systems with reduced impurities and related methods.
The present... |
|
|
Invention
|
Depot formulations.
Disclosed are formulations and related methods that comprise a non-polymeric... |
|
2022
|
Invention
|
Salts including crystalline salts of 25-hydroxy-cholest-5-en-3-sulfate and methods for preparing ... |
|
|
Invention
|
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involvin... |
|
|
Invention
|
25-hydroxy-cholest-5-en-3-sulfate choline and methods for preparing, and uses of, same. 25HC3S ch... |
|
|
Invention
|
Compositions and methods involving polymer, solvent and high viscosity liquid carrier material.
... |
|
|
Invention
|
Sustained release drug delivery systems and related methods. The present disclosure provides for ... |
|
2021
|
Invention
|
Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, c... |
|
|
Invention
|
Crystalline sodium cholesteryl sulfate.
Crystalline forms of crystalline sodium cholesteryl sulf... |
|
|
Invention
|
Crystalline thiocholesterol.
Crystalline forms of thiocholesterol are disclosed herein. Such for... |
|
|
Invention
|
Crystalline sodium cholesteryl sulfonate.
Crystalline and non-crystalline forms of crystalline s... |
|
|
Invention
|
Crystalline sodium cholesteryl sulfonate. Crystalline and non-crystalline forms of crystalline so... |
|
|
Invention
|
Crystalline sodium cholesteryl sulfate. Crystalline forms of crystalline sodium cholesteryl sulfa... |
|
|
Invention
|
Crystalline thiocholesterol. Crystalline forms of thiocholesterol are disclosed herein. Such form... |
|
|
Invention
|
Peroxide removal from drug delivery vehicle.
The present invention is related to methods for low... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for treating autoimmune conditions.
Aspects of the presen... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for cancers and non-cancerous transformations related to e... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for treating neurological conditions, neurodegenerative di... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for treating autoimmune conditions. Aspects of the present... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes,... |
|
|
Invention
|
Use of oxygenated cholesterol sulfates for treating inflammatory conditions. Aspects of the prese... |
|
|
Invention
|
Treatment of non-alcoholic steatohepatitis (nash). Methods of treating non-alcoholic steatohepati... |
|
|
Invention
|
Biodegradable drug delivery composition.
The present disclosure provides a biodegradable drug de... |
|
|
Invention
|
Treatment of infectious diseases.
Methods of treating infectious diseases are provided. For inst... |
|
|
Invention
|
Treatment of infectious diseases. Methods of treating infectious diseases are provided. For insta... |
|
|
Invention
|
Sustained release drug delivery systems with reduced impurities and related methods. The present ... |
|
2020
|
Invention
|
Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for prepa... |
|
|
Invention
|
Radiation-sterilized biodegradable drug delivery compositions.
The present disclosure is directe... |
|
|
Invention
|
Treatment of alcoholic hepatitis.
Methods of treating alcoholic hepatitis (AH) are provided. For... |
|
|
Invention
|
Long-acting formulations and vehicles.
The present disclosure provides long-acting formulations ... |
|
|
Invention
|
Long-acting formulations of tenofovir alafenamide.
The present disclosure provides long-acting f... |
|
2013
|
P/S
|
Surgical, medical, dental and veterinary materials, namely, pharmaceuticals and preparations for ... |
|
2011
|
P/S
|
Pharmaceutical transdermal or topical drug delivery formulations, namely, drug delivery agents co... |
|
2010
|
P/S
|
Pharmaceutical drug delivery systems, namely, drug delivery formulations used with various medica... |
|
2000
|
P/S
|
Miniature fluid dispensers for experimental use in laboratory animals and in vitro; implantable a... |
|
1976
|
P/S
|
Miniature fluid dispensers for experimental use in laboratory animals or in vitro.
Miniature flui... |
